May 13, 2021 at 4:30 PM EDT
Keyword Search
- Summary ToggleInfinity Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Company UpdateMay 13, 2021 at 4:05 PM EDT
- Summary ToggleInfinity to Present at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy 2021May 5, 2021 at 8:35 AM EDT
- Summary ToggleInfinity to Present at the 7th Annual Truist Securities Life Sciences SummitApril 27, 2021 at 8:35 AM EDT
- Summary ToggleInfinity to Present at the Oppenheimer & Co. Annual Healthcare ConferenceMarch 10, 2021 at 8:35 AM EST
- Summary ToggleInfinity to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 at 8:35 AM EST
- Summary ToggleInfinity Announces Closing of $92 Million Public Offering of Common StockFebruary 18, 2021 at 8:30 AM EST
- Summary ToggleInfinity Announces Pricing of $80 Million Public Offering of Common StockFebruary 12, 2021 at 8:30 AM EST